After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
SLDB belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Solid Biosciences Inc is $443.31M. A total of 0.84 million shares were traded on the day, compared to an average of 1.07M shares.
In the most recent transaction, Howton David T sold 4,932 shares of SLDB for 5.11 per share on Dec 03 ’25. After the transaction, the Chief Operating Officer now owns 32,908 company shares. In a previous transaction on Dec 03 ’25, Cumbo Alexander sold 10,808 shares at 5.11 per share. SLDB shares that President and CEO owns now total 81,388.
Among the insiders who sold shares, Hanrahan Jessie disposed of 4,483 shares on Dec 03 ’25 at a per-share price of $5.11. This resulted in the Chief Regulatory Officer holding 26,660 shares of SLDB after the transaction. In another insider transaction, Herzich Paul sold 2,701 shares at $5.11 per share on Dec 03 ’25. Company shares held by the Chief Technology Officer now total 26,622.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, SLDB has a high of $7.37 and a low of $2.41.
As of this writing, SLDB has an earnings estimate of -$0.5 per share for the current quarter. EPS was calculated based on a consensus of 13.0 estimates, with a high estimate of -$0.38 per share and a lower estimate of -$0.63. The company reported an EPS of -$1 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. SLDB’s latest balance sheet shows that the firm has $207.78M in Cash & Short Term Investments as of fiscal 2021. There were $2.06M in debt and $23.60M in liabilities at the time. Its Book Value Per Share was $2.80, while its Total Shareholder’s Equity was $208.21M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for SLDB is Buy with a score of 4.80.
